PDUFAconf 0.99

olutasidenib — PDUFA

$RIGL · RIGEL PHARMACEUTICALS INC · relapsed/refractory acute myeloid leukemia (R/R AML)

Event date

February 15, 2023

1207 days ago

Sponsor runway

cash-flow +

$146.7M liquid

Evidence

“The Prescription Drug User Fee Act (PDUFA) target action date is February 15, 2023.”

Source: Press release · 2022-08-02View press release ↗

Comparable historical pdufas· last 5 years · same event type

75% hit rate (3/4)

Ticker	Drug	Date	Outcome
$RCKT	kresladi	2026-03-28	success
$RYTM	imcivree	2026-03-20	success
$CYTK	aficamten	2025-12-26	unknown
$ALDX	reproxalap	2025-12-16	unknown
$BCRX	orladeyo	2025-12-12	success
$OMER	narsoplimab	2025-09-25	unknown
$BCRX	orladeyo (berotralstat)	2025-09-12	unknown
$ETON	et-400	2025-05-28	unknown
$ALDX	reproxalap	2025-04-02	failure
$IONS	olezarsen	2024-12-19	unknown

Recent insider activity· ±90 days

4 insiders · 0 buys · 4 sells

Sell

2023-02-06

RODRIGUEZ RAUL R

CEO, President

20,340 @ $1.75$36K

Sell

2023-02-02

Dummer Wolfgang

EVP & CMO

5,389 @ $1.66$9K

Sell

2023-02-02

Schorno Dean L

EVP & Chief Financial Officer

5,389 @ $1.66$9K

Sell

2023-02-02

Santos David A

EVP, Chief Commercial Officer

5,388 @ $1.66$9K

Grant

2023-01-26

Dummer Wolfgang

EVP & CMO

50,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

80,000 @ ——

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

300,000 @ ——

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

600,000 @ ——

Grant

2023-01-26

RODRIGUEZ RAUL R

CEO, President

200,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

160,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

63,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

50,000 @ ——

Grant

2023-01-26

Schorno Dean L

EVP & Chief Financial Officer

125,000 @ ——

Grant

2023-01-26

Santos David A

EVP, Chief Commercial Officer

50,000 @ ——

Grant

2022-12-28

Dummer Wolfgang

EVP & CMO

50,000 @ ——

Grant

2022-12-28

RODRIGUEZ RAUL R

CEO, President

200,000 @ ——

Grant

2022-12-28

Schorno Dean L

EVP & Chief Financial Officer

50,000 @ ——

Grant

2022-12-28

Santos David A

EVP, Chief Commercial Officer

50,000 @ ——

Date	Insider	Action	Shares	Price	Value
2023-02-06	RODRIGUEZ RAUL RCEO, President	Sell	20,340	$1.75	$36K
2023-02-02	Dummer WolfgangEVP & CMO	Sell	5,389	$1.66	$9K
2023-02-02	Schorno Dean LEVP & Chief Financial Officer	Sell	5,389	$1.66	$9K
2023-02-02	Santos David AEVP, Chief Commercial Officer	Sell	5,388	$1.66	$9K
2023-01-26	Dummer WolfgangEVP & CMO	Grant	50,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	80,000	—	—
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	300,000	—	—
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	600,000	—	—
2023-01-26	RODRIGUEZ RAUL RCEO, President	Grant	200,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	160,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	63,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	50,000	—	—
2023-01-26	Schorno Dean LEVP & Chief Financial Officer	Grant	125,000	—	—
2023-01-26	Santos David AEVP, Chief Commercial Officer	Grant	50,000	—	—
2022-12-28	Dummer WolfgangEVP & CMO	Grant	50,000	—	—
2022-12-28	RODRIGUEZ RAUL RCEO, President	Grant	200,000	—	—
2022-12-28	Schorno Dean LEVP & Chief Financial Officer	Grant	50,000	—	—
2022-12-28	Santos David AEVP, Chief Commercial Officer	Grant	50,000	—	—

← All catalysts for $RIGL